Inova Schar Heart and Vascular
@ISHVnews
Followers
2K
Following
183
Media
886
Statuses
2K
Our award-winning team is focused on innovation and excellence in cardiovascular research and patient care.
Northern Virginia & DC Metro
Joined January 2016
HF prevalence & mortality are high in older adults. In #JACCAdvances, @Yasserjamil_MD and @marcsamsky examine whether adults ≥75 years, specifically women & racial/ethnic minorities, are adequately represented in contemporary HF guidelines @coconnormd @DrDamluji
0
1
8
Excellent seminar on a critically important area. Proud of our Echo teams for sharing their expertise!
From Echo Image to Diagnosis- Sonographer is a key to high quality CV care. Learning from and with the Best! our @ISHVnews Echo teams at Sonographer led seminar. @RezaEmaminia @InovaHealth @InovaCVfellows
0
0
7
Nice work! Congratulations
Excited to be in NYC for @nyulangone #CritCareCards25! 🫀🔥 Presenting 2 complex clinical cases. Use of ECPELLA in SCAI D/E as a bridge to native myocardial recovery selected as a top 10 finalist for @CardioNerds poster session 💜🤓 @InovaCVfellows @ISHVnews @ShashankSinhaMD
0
1
16
An impactful Keynote Address by @ShashankSinhaMD at the VHAC statewide meeting Thrilled that the leader of the @ISHVnews nationally recognized CS program had the opportunity to share insights on processes and procedures to improve care delivery and patient outcomes.
1
4
12
Have patients said to have recovered from CS really recovered? In @JCardFail, @vbluml argues against equating survival with recovery. Proposes a lexicon that distinguishes survival, remission, & recovery as discrete, clinically meaningful outcomes https://t.co/O70Taxc2qz
0
3
9
In #JACCHF Position Statement, @AdityaMehtaMD, @PalakShahMD et al highlight diagnostic & therapeutic approaches to AMR, the leading cause of graft failure and mortality after heart transplantation. https://t.co/J5U8OpvHZg
0
9
15
Approach, safety, patient selection and outcomes of uRDN with Paradise™ at @ISHVnews described in interview with Dr. Behnam Tehrani, in @CathLabDigest Proud to be among the first to adopt this technology to improve the lives of our patients. https://t.co/Cul3zkX614
0
2
6
Thrilled to partner with @MGHWomenHeart to offer #CardioObstetrics #WomensCVH #YIA competition. Abstracts due 1/9/26. Top 3 travel to @ISHVnews in No. Virginia to present. Email Elizabeth.Wilson@Inova.org for information @GarimaVSharmaMD @coconnormd
0
3
12
Pearls of wisdom from one of our incredible APDs! Lucky to learn from @vbluml and the rest of our CS team to provide the best care for our patients @ISHVnews
🚨Final #HFSA2025 Simpub! In this 🔥ECT Spotlight, @vbluml describes the critical distinction between native 🫀 survival, remission & recovery in CS, underscoring the implications of precise terminology for clinical care, research, & systems of care. 🔗 https://t.co/ej0LVCmGrp
1
4
18
Proud to see @InovaHealth @mpsotka @ShashankSinhaMD @vbluml leading key #HFSA conversations at this great meeting focused on patients, collaboration and innovation. At a global and local level. @coconnormd @ISHVnews @InovaCVfellows
Day 2 of #HFSA Scientific Sessions: our #HFC members continue to lead the conversation with their advances and insights We’re proud to see their work driving progress and collaboration in heart failure care 💙 Here’s the agenda for day two featuring HFC members👇
0
6
23
Great first day! Successful high risk PCI with arthrectomy and stent for patient with CTO -- by our new faculty member @ArabaOSIII Excited to have you back with us!
0
2
24
Great perspectives and insight on an important aspect of research @coconnormd @GarimaVSharmaMD @InovaCVfellows @ShashankSinhaMD @mpsotka @SumeetMitter
Should investigators have access to clinical trial data? We tackle the pros & cons in our latest #HFC podcast. Listen to the full episode here: https://t.co/EM4iop21DV
#heartfailure #clinicaltrials #podcast #newepisode #CardioTwitter
0
3
5
Can mammographic images combined with BAC and age predict MACE as JY Barraclough, et al suggest in @Heart_BMJ
https://t.co/ocqNqWg3KY
@AnaBaracCardio questions the drivers of risk and implementation of results in @TCTMD
https://t.co/9FVomomnrc
tctmd.com
The deep-learning model used the whole “breast architecture,” not just calcification, to predict MACE risk in middle-aged women.
0
0
3
Great Friday at @SCAI Shock. @ISHVnews Superstar Fellow @ilanvavilinmd presented a case of AMI CS escalating to Impella 5.5 @ShashankSinhaMD on SCAI Staging & CS controversies in Trials @JamieLWKennedy on RV-CS Program Co-Chair Behnam Tehrani & @agtruesdell - Challenging Cases
1
4
19
Our @ISHVnews CS experts share experiences with Multidisciplinary Shock Team approach
Kicking off the @SocietyOfCCC and @SCAI Cardiogenic Shock Team Think Tank w/ diverse perspectives from diverse stakeholders!
1
1
13
Big winners regardless of the score…. So proud to have our D’Aniello and Schar Endowed chairs recognized and celebrated at DC United game last night. Thank you for your commitment to excellence!
2
12
22
At Inova 2025 CV Symposium Comprehensive update by @mpsotka on HF trial results from recent national and international meetings followed by lively discussion of new and older therapies @JamieLWKennedy @DoctorRTC
@vbluml @ShashankSinhaMD
0
1
10
Off to an amazing start at Inova 2025 CV Symposium with latest thinking on Prevention --- Risk Factors, PREVENT, with special emphasis on new ACC/AHA Hypertension guidelines @GarimaVSharmaMD @JSpitz_MD @DrDastmalchi @AnaBaracCardio @TariqHaddadMD @jason_bonomo
0
9
23
Cardiometabolic change in menopause elevates CV risk, but this remains under-recognized. In @ACCinTouch interview @a_l_bailey, @DrDastmalchi discuss ways to improve CV Clinical competencies for Menopausal Transition https://t.co/g1q6cVxCUF
acc.org
0
4
8
A Commentary in latest issue of #JACC, by @ISHVnews @vbluml on behalf of @hfcollaboratory proposes designation/definition of a cardiogenic “preshock” state where early intervention may favorably alter clinical trajectory. https://t.co/5LMuaV4W3R
0
4
12